Table 1.
The baseline characteristics of patients with early-stage cervical cancer
| Variables | ARH group | LRH group | RRH group | VRH group | P value |
|---|---|---|---|---|---|
| No. of patients | 32 | 61 | 100 | 45 | |
| Age (years old) | 50.13 ± 8.89 | 48.97 ± 8.59 | 48.64 ± 9.89 | 46.04 ± 8.16 | 0.220 |
| BMI (kg/m2) | 25.42 ± 3.24 | 24.06 ± 2.81 | 24.12 ± 3.50 | 24.15 ± 3.23 | 0.210 |
| FIGO stage | 0.701 | ||||
| IA2 | 0 (0.00%) | 5 (8.20%) | 5 (5.00%) | 3 (6.67%) | |
| IB1 | 31 (96.88%) | 52 (85.24%) | 91 (91.00%) | 40 (88.89%) | |
| IB2 | 1 (3.12%) | 4 (6.56%) | 4 (4.00%) | 2 (4.44%) | |
| Histology | 0.444 | ||||
| Squamous cell carcinoma | 26 (81.25%) | 49 (80.33%) | 89 (89.00%) | 40 (88.89%) | |
| Adenocarcinoma | 6 (18.75%) | 11 (18.03%) | 11 (11.00%) | 4 (8.89%) | |
| Adenosquamous carcinoma | 0 (0.00%) | 1 (1.64%) | 0 (0.00%) | 1 (2.22%) | |
| Postoperative adjuvant therapy | 16 (50.00%) | 33 (54.10%) | 55 (55.00%) | 22 (48.89%) | 0.894 |
BMI Body mass index in kg/cm2, FIGO International Federation for Gynaecology and Obstetrics